Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAF312 for Postoperative Ocular Pain in PRK
NCT02961062Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SAF312 in post-operative ocular pain, sponsored by Novartis. Started Dec 2016; status: completed.
02
Drugs
SAF312
03
Conditions
post-operative ocular pain
Beyond the preview
Go deeper on NCT02961062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02961062.